Quinoxaline 1,4-dioxides as anticancer and hypoxia-selective drugs

Oncology Reports

Volumn 8, Issue 3, 2001, Pages 679-684

  Gali Muhtasib, Hala U ^a  

^a AMERICAN UNIVERSITY OF BEIRUT   (Lebanon)

Author keywords

Bioreductive drugs; Cell cycle; Cell proliferation; Growth inhibition; Hypoxia; Quinoxaline 1,4 dioxides

Indexed keywords

ANTINEOPLASTIC AGENT; QUINDOXIN; QUINOXALINE DERIVATIVE;

ARTICLE; CELL CULTURE; CELL CYCLE; CELL HYPOXIA; CELL LINE; CELL SURVIVAL; CHEMICAL STRUCTURE; CHEMISTRY; DOSE RESPONSE; DRUG EFFECT; DRUG TOXICITY; HUMAN;

ANTINEOPLASTIC AGENTS; CELL CYCLE; CELL HYPOXIA; CELL LINE; CELL SURVIVAL; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG TOXICITY; HUMANS; MOLECULAR STRUCTURE; QUINOXALINES; TUMOR CELLS, CULTURED;

EID: 0035346937     PISSN: 1021335X     EISSN: None     Source Type: Journal    
DOI: 10.3892/or.8.3.679     Document Type: Article

References (2)

1. Hoskin BD and Lyon PM: The effect of quindoxin on the growth of broiler chickens. Vet Rec 90: 396-399, 1972.
2. Suter W, Rosselet A and Knusel F: Mode of action of quindoxin and substituted quinoxaline-di-N-oxides on Escherichia coll. Antimicrobial Agents Chemother 13: 770-783, 1978.